Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Liem

Showing results (181-190 of 195) with videos related to

Pageof 20
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 14, 2026
Prognostic host phenotypes based on body composition and systemic inflammation predict survival in patients with resected pancreatic and periampullary cancerNicole D Hildebrand, David P J van Dijk, Jisce R Puik, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|June 1, 2022
Outcomes of the first global multidisciplinary consensus meeting including persons living with obesity to standardize patient-reported outcome measurement in obesity treatment researchClaire E E de Vries, Caroline B Terwee, May Al Nawas, et al.
Hepatology Communications|November 3, 2022
A nationwide assessment of hepatocellular adenoma resection: Indications and pathological discordanceMartijn P D Haring, Arthur K E Elfrink, Christiaan A J Oudmaijer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 28, 2025
Timing of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: A nationwide analysisP C M Andel, I W J M van Goor, N C Biesma, et al.
BMC Cancer|August 7, 2023
Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trialJ L van Dam, E M M Verkolf, E N Dekker, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2024
Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validationJ Michiel Zeeuw, Nina J Wesdorp, Mahsoem Ali, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2025
Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trialJ Michiel Zeeuw, Ruby Kemna, Mahsoem Ali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2026
Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 TrialRuth A L Willems, Aniek E van Diepen, Esther N Dekker, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|October 17, 2024
A Core set of patient-reported outcome measures to measure quality of life in obesity treatment researchPhillip J Dijkhorst, Claire E E de Vries, Caroline B Terwee, et al.
JAMA Network Open|March 31, 2026
Radiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer: The PELICAN Randomized Clinical TrialLeonard W F Seelen, Lilly J H Brada, Marieke S Walma, et al.
Pageof 20

Showing results (181-190 of 195) with videos related to

Sort By:
Pageof 20
European Journal of Cancer (Oxford, England : 1990)|July 14, 2026
Prognostic host phenotypes based on body composition and systemic inflammation predict survival in patients with resected pancreatic and periampullary cancerNicole D Hildebrand, David P J van Dijk, Jisce R Puik, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|June 1, 2022
Outcomes of the first global multidisciplinary consensus meeting including persons living with obesity to standardize patient-reported outcome measurement in obesity treatment researchClaire E E de Vries, Caroline B Terwee, May Al Nawas, et al.
Hepatology Communications|November 3, 2022
A nationwide assessment of hepatocellular adenoma resection: Indications and pathological discordanceMartijn P D Haring, Arthur K E Elfrink, Christiaan A J Oudmaijer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 28, 2025
Timing of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: A nationwide analysisP C M Andel, I W J M van Goor, N C Biesma, et al.
BMC Cancer|August 7, 2023
Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trialJ L van Dam, E M M Verkolf, E N Dekker, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2024
Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validationJ Michiel Zeeuw, Nina J Wesdorp, Mahsoem Ali, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2025
Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trialJ Michiel Zeeuw, Ruby Kemna, Mahsoem Ali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2026
Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 TrialRuth A L Willems, Aniek E van Diepen, Esther N Dekker, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|October 17, 2024
A Core set of patient-reported outcome measures to measure quality of life in obesity treatment researchPhillip J Dijkhorst, Claire E E de Vries, Caroline B Terwee, et al.
JAMA Network Open|March 31, 2026
Radiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer: The PELICAN Randomized Clinical TrialLeonard W F Seelen, Lilly J H Brada, Marieke S Walma, et al.
Pageof 20